ADMA Biologics Inc (ADMA) — Cash Flow Reinvestment Rate
ADMA Biologics Inc (ADMA) has a Cash Flow Reinvestment Rate of 0.08x as of June 2026, reinvesting $2.26 Million (capex $2.26 Million ) from operating cash flow of $29.54 Million. See ADMA FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
ADMA Biologics Inc Cash Flow Reinvestment Rate (2023–2025)
Historical reinvestment intensity for ADMA Biologics Inc across 3 annual periods. For the full cash flow conversion analysis, see ADMA Biologics Inc (ADMA) cash conversion ratio.
Annual Cash Flow Reinvestment Rate for ADMA Biologics Inc (2023–2025)
Year-by-year capital reinvestment analysis for ADMA Biologics Inc. See ADMA FCF to total liabilities ratio to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.45x | $22.57 Million | $50.40 Million | $22.57 Million | ▲ +210.0% |
| 2024 | 0.14x | $17.15 Million | $118.67 Million | $8.57 Million | ▼ -89.7% |
| 2023 | 1.40x | $12.30 Million | $8.80 Million | $4.98 Million | — |